The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Nanobody: outstanding features for diagnostic and therapeutic applications
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Naturally occurring antibodies devoid of light chains
Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hammers, C., Songa, E. B., Bendahman, N., & Hammers, R. (1993) · Nature · doi:10.1038/363446a0 · Cited by 3,241
Nanobodies: natural single-domain antibodies
Muyldermans, S. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-063011-092449 · Cited by 2,304
A general protocol for the generation of Nanobodies for structural biology
Pardon, E., Laeremans, T., Triest, S., Rasmussen, S. G. F., Wohlkönig, A., Ruf, A., Muyldermans, S., Hol, W. G. J., Kobilka, B. K., & Steyaert, J. (2014) · Nature Protocols · doi:10.1038/nprot.2014.039 · Cited by 790
Selection and identification of single domain antibody fragments from camel heavy‐chain antibodies
Arbabi Ghahroudi, M., Desmyter, A., Wyns, L., Hamers, R., & Muyldermans, S. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01062-4 · Cited by 768
Single‐domain antibody fragments with high conformational stability
Dumoulin, M., Conrath, K., Van Meirhaeghe, A., Meersman, F., Heremans, K., Frenken, L. G. J., Muyldermans, S., Wyns, L., & Matagne, A. (2002) · Protein Science · doi:10.1110/ps.34602 · Cited by 638
Vincke, C., Loris, R., Saerens, D., Martinez-Rodriguez, S., Muyldermans, S., & Conrath, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806889200 · Cited by 572
Camelid immunoglobulins and nanobody technology
Muyldermans, S., Baral, T. N., Retamozzo, V. C., De Baetselier, P., De Genst, E., Kinne, J., Leonhardt, H., Magez, S., Nguyen, V. K., Revets, H., et al. (2009) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2008.10.299 · Cited by 533
Potent enzyme inhibitors derived from dromedary heavy-chain antibodies
Lauwereys, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3512 · Cited by 490
Nanobodies as therapeutics: big opportunities for small antibodies
Steeland, S., Vandenbroucke, R. E., & Libert, C. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.04.003 · Cited by 468
Structural and thermodynamic analysis of the GFP:GFP‐nanobody complex
Kubala, M. H., Kovtun, O., Alexandrov, K., & Collins, B. M. (2010) · Protein Science · doi:10.1002/pro.519 · Cited by 400
Durable antitumor responses to CD47 blockade require adaptive immune stimulation
Sockolosky, J. T., Dougan, M., Ingram, J. R., Ho, C. C. M., Kauke, M. J., Almo, S. C., Ploegh, H. L., & Garcia, K. C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604268113 · Cited by 366
Crivianu-Gaita, V., & Thompson, M. E. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.04.091 · Cited by 365
β-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae
Conrath, K. E., Lauwereys, M., Galleni, M., Matagne, A., Frère, J.-M., Kinne, J., Wyns, L., & Muyldermans, S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2807-2812.2001 · Cited by 347
Els Conrath, K., Lauwereys, M., Wyns, L., & Muyldermans, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007734200 · Cited by 300
Bispecific antibodies: design, therapy, perspectives
Sedykh, S., Prinz, V., Buneva, V., & Nevinsky, G. (2018) · Drug Design, Development and Therapy · doi:10.2147/dddt.s151282 · Cited by 292
Nanobodies: Chemical Functionalization Strategies and Intracellular Applications
Schumacher, D., Helma, J., Schneider, A. F. L., Leonhardt, H., & Hackenberger, C. P. R. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201708459 · Cited by 260
Exploiting Nanobodies’ Singular Traits
Ingram, J. R., Schmidt, F. I., & Ploegh, H. L. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053327 · Cited by 254
Gainkam, L. O. T., Huang, L., Caveliers, V., Keyaerts, M., Hernot, S., Vaneycken, I., Vanhove, C., Revets, H., De Baetselier, P., & Lahoutte, T. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.048538 · Cited by 222
Thermal Unfolding of a Llama Antibody Fragment: A Two-State Reversible Process
Pérez, J. M. J., Renisio, J. G., Prompers, J. J., van Platerink, C. J., Cambillau, C., Darbon, H., & Frenken, L. G. J. (2001) · Biochemistry · doi:10.1021/bi0009082 · Cited by 199
Alternative affinity tools: more attractive than antibodies?
Ruigrok, V. J. B., Levisson, M., Eppink, M. H. M., Smidt, H., & van der Oost, J. (2011) · Biochemical Journal · doi:10.1042/bj20101860 · Cited by 194
The structural basis of nanobody unfolding reversibility and thermoresistance
Kunz, P., Zinner, K., Mücke, N., Bartoschik, T., Muyldermans, S., & Hoheisel, J. D. (2018) · Scientific Reports · doi:10.1038/s41598-018-26338-z · Cited by 181
Nanobodies as novel agents for disease diagnosis and therapy
Siontorou, C. G. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s39428 · Cited by 175
Antibody Fragments as Probe in Biosensor Development
Saerens, D., Huang, L., Bonroy, K., & Muyldermans, S. (2008) · Sensors · doi:10.3390/s8084669 · Cited by 169
X-Ray Crystallography of Antibodies
Padlan, E. A. (1996) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60488-x · Cited by 165
Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies
Wolfgang, W. J., Miller, T. W., Webster, J. M., Huston, J. S., Thompson, L. M., Marsh, J., & Messer, A. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505321102 · Cited by 162
VHH antibodies: emerging reagents for the analysis of environmental chemicals
Bever, C. S., Dong, J., Vasylieva, N., Barnych, B. B., Cui, Y., Xu, Z.-L., Hammock, B. D., & Gee, S. J. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9585-x · Cited by 157
Davies, J., & Riechmann, L. (1996) · Protein Engineering Design and Selection · doi:10.1093/protein/9.6.531 · Cited by 155
Tang, X., Li, P., Zhang, Q., Zhang, Z., Zhang, W., & Jiang, J. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b02794 · Cited by 155
Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications
Wang, Y., Fan, Z., Shao, L., Kong, X., Hou, X., Tian, D., Sun, Y., Xiao, Y., & Yu, L. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s107194 · Cited by 153
Expression of single-domain antibody in different systems
Liu, Y., & Huang, H. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8644-3 · Cited by 141
Lafaye, P. J., Achour, I., England, P., Duyckaerts, C. J., & Rougeon, F. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.09.008 · Cited by 131
Recent advances in the selection and identification of antigen-specific nanobodies
Liu, W., Song, H., Chen, Q., Yu, J., Xian, M., Nian, R., & Feng, D. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.02.012 · Cited by 130
Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection
Ibañez, L. I., Filette, M. D., Hultberg, A., Verrips, T. C., Temperton, N. J., Weiss, R. A., Vandevelde, W., Schepens, B., Vanlandschoot, P., & Saelens, X. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq168 · Cited by 127
Under the Microscope: Single-Domain Antibodies for Live-Cell Imaging and Super-Resolution Microscopy
Traenkle, B., & Rothbauer, U. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01030 · Cited by 122
Torres, J. E. P., Goossens, J., Ding, J., Li, Z., Lu, S., Vertommen, D., Naniima, P., Chen, R., Muyldermans, S., Sterckx, Y. G. ‐., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26732-7 · Cited by 108
Debie, P., Quathem, J. V., Hansen, I., Bala, G., Massa, S., Devoogdt, N., Xavier, C., & Hernot, S. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01053 · Cited by 106
Generation of llama single-domain antibodies against methotrexate, a prototypical hapten
Alvarez-Rueda, N., Béhar, G., Ferré, V., Pugnière, M., Roquet, F., Gastinel, L. N., Jacquot, C., Aubry, J., Baty, D., Barbet, J., et al. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.08.007 · Cited by 100
Kim, H. J., McCoy, M. R., Májková, Z., Dechant, J. E., Gee, S. J., Rosa, S. T.-D., González‐Sapienza, G., & Hammock, B. D. (2011) · Analytical Chemistry · doi:10.1021/ac2030255 · Cited by 90
Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment
Iezzi, M. E., Policastro, L., Werbajh, S., Podhajcer, O. L., & Canziani, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00273 · Cited by 87
Liu, X., Tang, Z., Duan, Z., He, Z., Shu, M., Wang, X., Gee, S. J., Hammock, B. D., & Xu, Y. (2016) · Talanta · doi:10.1016/j.talanta.2016.11.039 · Cited by 86
Wang, J., Bever, C. S., Májková, Z., Dechant, J. E., Yang, J., Gee, S. J., Xu, T., & Hammock, B. D. (2014) · Analytical Chemistry · doi:10.1021/ac5017437 · Cited by 79
Fodey, T. L., Leonard, P., O’Mahony, J., O’Kennedy, R. J., & Danaher, M. (2010) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2010.10.011 · Cited by 78
Unger, M., Eichhoff, A. M., Schumacher, L., Strysio, M., Menzel, S., Schwan, C., Alzogaray, V., Zylberman, V., Séman, M., Brandner, J. M., et al. (2015) · Scientific Reports · doi:10.1038/srep07850 · Cited by 75
Tu, Z., Chen, Q., Li, Y., Xiong, Y., Xu, Y., Hu, N., & Tao, Y. (2015) · Analytical Biochemistry · doi:10.1016/j.ab.2015.09.023 · Cited by 57
VHH Antibodies: Reagents for Mycotoxin Detection in Food Products
Wang, J., Mukhtar, H., Ma, L., Pang, Q., & Wang, X. (2018) · Sensors · doi:10.3390/s18020485 · Cited by 53
Certolizumab Pegol: In Crohn??s Disease
Blick, S. K. A., & Curran, M. P. (2007) · BioDrugs · doi:10.2165/00063030-200721030-00006 · Cited by 53
Campuzano, S., Salema, V. F., Moreno‐Guzmán, M., Gamella, M., Yáñez‐Sedeño, P., Fernández, L. Á., & Pingarrón, J. M. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.08.055 · Cited by 50
Alemtuzumab in Chronic Lymphocytic Leukemia
Fraser, G. A. M., Smith, C. A., Imrie, K., Meyer, R. M., & The Hematology Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care (2007) · Current Oncology · doi:10.3747/co.2007.118 · Cited by 46
Wang, J., Májková, Z., Bever, C. S., Yang, J., Gee, S. J., Li, J., Xu, T., & Hammock, B. D. (2015) · Analytical Chemistry · doi:10.1021/ac504735p · Cited by 46
Robert, B., Dorvillius, M., Buchegger, F., Garambois, V., Mani, J. C., Pugni�res, M., Mach, J., & P�legrin, A. (1999) · International Journal of Cancer · Cited by 42
Qiu, Y., Li, P., Dong, S., Zhang, X., Yang, Q., Wang, Y., Ge, J., Hammock, B. D., Zhang, C., & Liu, X. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b04923 · Cited by 40
Crystal Structure of a ligand-bound LacY–Nanobody Complex
Kumar, H., Finer-Moore, J. S., Jiang, X., Смирнова, И. Н., Kasho, V. N., Pardon, E., Steyaert, J., Kaback, H. R., & Stroud, R. M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801774115 · Cited by 36
McMurphy, T. B., Xiao, R., Magee, D., Slater, A., Zabeau, L., Tavernier, J. H., & Cao, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089895 · Cited by 30
The case for pathogen-specific therapy
Casadevall, A. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903066837 · Cited by 28
Intracellular Delivery of Nanobodies for Imaging of Target Proteins in Live Cells
Röder, R., Helma, J., Preiß, T., et al. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2052-8 · Cited by 27
Zafra, O., Fraile, S., Gutiérrez, C., Haro, A., Páez-Espino, D., Jiménez, J. I., & de Lorenzo, V. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2010.02401.x · Cited by 24
Makvandi‐Nejad, S., Fjällman, T., Arbabi‐Ghahroudi, M., MacKenzie, C. R., & Hall, J. C. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.07.006 · Cited by 18
Cited by
Pharmacological Inhibitors of the NLRP3 Inflammasome
Zahid, A., Li, B., Kombe, A. J. K., Jin, T., & Tao, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02538 · Cited by 671
NANOBODIES®: A Review of Diagnostic and Therapeutic Applications
Jin, B.-K., Odongo, S., Radwanska, M., & Magez, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065994 · Cited by 371
Gao, L., Wang, J., & Bi, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s549893 · Cited by 52
Chen, Z.-S., Huang, H.-C., Wang, X., Schön, K., Jia, Y., Lebens, M., Besavilla, D. F., Murti, J. R., Ji, Y., Sarshad, A. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55193-y · Cited by 39
Advancements in Nanobody Epitope Prediction: A Comparative Study of AlphaFold2Multimer vs AlphaFold3
Eshak, F., & Goupil-Lamy, A. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01877 · Cited by 34
Metadata
- Authors
- Salvador, J.-P., Vilaplana, L., & Marco, M.-P.
- Venue
- Analytical and Bioanalytical Chemistry
- Published
- 2019-02-08
- Volume
- 411
- Issue
- 9
- Pages
- 1703-1713
- ISSN
- 1618-2642 (ISSN-L)
- 1618-2650
- OpenAlex
- W2913862398
- Cited by
- 350
- References
- 58
- FWCI
- 18.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.